2021 Pediatric Grand Rounds | Caring for Children with Cancer Predisposition Syndromes: An Evolving Landscape

Duarte, CA US
August 26, 2021

Technical advances in genomic medicine make identifying germline cancer mutations both easier and more accessible.  Novel associations are being identified and recommendations continue to evolve as more data is acquired regarding recognizing and caring for this population.  It is imperative to provide pediatric oncologists with the state of the science and help them understand the array of pediatric cancer predisposition syndromes currently known. The purpose of this lecture is to update pediatric oncologists on cancer predisposition syndromes that impact pediatric patients, and help them integrate best practices into clinical care.    
 

Target Audience

City of Hope Pediatric Hematology/Oncology physicians, advance practice practitioners, City of Hope staff and research teams.

Learning Objectives

  • Identify indications for germline evaluation to identify a cancer predisposition syndrome.
  • Integrate diagnostic algorithms for germline evaluation into clinical care.
  • Outline management alterations based on identification of a cancer predisposition syndrome.
  • Identify cancer predisposition syndromes that affect pediatric patients.

Additional Information

AttachmentSize
PDF icon AB 1195 Bibliography158.94 KB
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Caring for Children with Cancer Predisposition Syndromes: An Evolving Landscape for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
08/26/2021
Activity expires: 
08/31/2021
Event starts: 
08/26/2021 - 12:00pm
Event ends: 
08/26/2021 - 1:00pm
City of Hope
1500 E Duarte Rd
Duarte, CA 91010
United States

Virtual Meeting- Zoom

Junne Kamihara, MD, PhD   Instructor in Pediatrics; Co-Director, Pediatric Cancer Genetic Risk Program; Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Dr. Kamihara has indicated that her Spouse receives Grant/Research Support from ACD-Biotechne, PureTech Health, and Ribon Therapeutics; is a Consultant for Foundation Medicine, NanoString Technologies, Pfizer, and ROME Therapeutics; and a Stock/Shareholder in PanTher Therapeutics, ROME Therapeutics, and TellBio, Inc.

Dr. Kamihara will be discussing the off-label or investigational use of Belzutifan.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

 AMA PRA Category 1 Credit™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this 2021 Pediatric Grand Rounds | Caring for Children with Cancer Predisposition Syndromes: An Evolving Landscape for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.